A new study shows SARS-CoV-2-related coronaviruses are circulating in bats and a pangolin in Thailand, suggesting a wider distribution of such viruses across Southeast Asia.
- First and only study to give molecular and serological evidence that SARS-CoV-2-related coronaviruses circulate in bats and pangolins in Southeast Asia
- High diversity of SARS-CoV-2-related coronaviruses in the region makes finding the immediate progenitor virus of SARS-CoV-2 with intensified and internationally coordinated surveillance highly possible
While the World Health Organization (WHO) continues its mission to Wuhan investigating the origin and early transmission of SARS-CoV-2, the virus that causes COVID-19, a new study led by scientists from Duke-NUS Medical School, Singapore, and Chulalongkorn University, Thailand, shows that SARS-CoV-2-related coronaviruses (SC2r-CoVs) are circulating in animals as far away as Thailand. The study, published in Nature Communications, reported that high levels of neutralizing antibodies against the virus were present in both bats and pangolins found in the Southeast Asian country. The study further indicates that more SC2r-CoVs are likely to be discovered in the region. Southeast Asia with its large and diverse bat populations may be a more likely hotspot for such viruses.
“This is an important discovery in the search for the origin of SARS-CoV-2, which was made possible by rapid application of cutting-edge technology through transparent international collaboration,” said Dr. Supaporn Wacharapluesadee, from Thai Red Cross Emerging Infectious Diseases Health Science Centre, Faculty of Medicine, Chulalongkorn University, Bangkok Thailand.
High Antibody Levels in Bats and Pangolins
In the study, the team examined Rhinolophus bats in a Thai cave. SARS-CoV-2 neutralizing antibodies were detected in bats of the same colony and in a pangolin at a wildlife checkpoint in Southern Thailand.
“Our study extended the geographic distribution of genetically diverse SARS-CoV-2-related coronaviruses from Japan and China to Thailand over a 4,800-km (3,000-mi) range. Cross-border surveillance is urgently needed to find the immediate progenitor virus of SARS-CoV-2,” said Dr. Chee Wah Tan, Senior Research Fellow with Duke-NUS’ Emerging Infectious Diseases (EID) program and co-author of this study.
Novel Antibody Test Used in Wildlife Surveillance
The team conducted serological investigations using the SARS-CoV-2 surrogate virus neutralization test (sVNT) developed at Duke-NUS in early 2020.
“Our study demonstrates that our SARS-CoV-2 surrogate virus neutralization test, developed mainly for determining neutralizing antibodies in humans to monitor vaccine efficacy and detect past infections, can also be critical for tracing the animal origin and animal-human spillover events,” said Professor Wang Linfa from Duke-NUS’ EID program and corresponding author of this study.
Prof Wang’s team invented the sVNT assay, trade named cPass, which has been granted Emergency Use Authorisation by the US FDA to determine SARS-CoV-2-neutralising antibodies in human sera, due to its good performance concordance with live virus-based assays.
“Studies like this are crucial in furthering our understanding of the many SARS-CoV-2-related viruses that exist in the wild. This work is also timely as investigations into the origins of SARS-CoV-2 are ongoing and may provide further leads on the origin of this outbreak. Such studies also play a key role in helping us be better prepared against future pandemics as they provide a more detailed map of zoonotic threats, ” said Prof Patrick Casey, Senior Vice Dean for Research at Duke-NUS.
Reference: “Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia” by Supaporn Wacharapluesadee, Chee Wah Tan, Patarapol Maneeorn, Prateep Duengkae, Feng Zhu, Yutthana Joyjinda, Thongchai Kaewpom, Wan Ni Chia, Weenassarin Ampoot, Beng Lee Lim, Kanthita Worachotsueptrakun, Vivian Chih-Wei Chen, Nutthinee Sirichan, Chanida Ruchisrisarod, Apaporn Rodpan, Kirana Noradechanon, Thanawadee Phaichana, Niran Jantarat, Boonchu Thongnumchaima, Changchun Tu, Gary Crameri, Martha M. Stokes, Thiravat Hemachudha and Lin-Fa Wang, 9 February 2021, Nature Communications.
DOI: 10.1038/s41467-021-21240-1
Never miss a breakthrough: Join the SciTechDaily newsletter.
Follow us on Google and Google News.
1 Comment
I propose that originally the Corona virus was created in a lab environment by selecting a bat species from islands close to China. Then testing how sick the bat can get without dying by injections until there is a base line to formulate the strongest virus the bat can handle. A virus that will remain in the bat without killing it constantly mutating over about 40 years till it becomes strong enough for human transmission like SARS and Covid. Much like AIDS in chimpanzees can be harmful to humans but not deadly to the chimpanzee. So has Corona a place in bats without being deadly to the chosen host. The virus is doing exactly what it was engineered to do be placed in the environment 40 years ago so that no body would suggest that it was put there engineered by man to sit on mother nature’s shelf until it serves it’s propose when it predictively sweeps thru humanity like AIDS did in the 1980s. It’s not nice to think about but it is totally plausible. 🦇🌏 The only real question is not about Corona or AIDS it’s about what’s next?